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1  | INTRODUC TION
Dental erosion is a common problem that has received significant 
attention in the literature.1 Although dental erosion can be found 
across all age groups, it is of particular concern when identified in 
very young children due to the development of dietary habits that 
result in irreversible enamel loss. In a sampling of young adults, 
Bartlett et  al2 reported 29% of participants 15‐35 years old showed 
symptoms of erosive tooth wear. In a systematic literature review, 
Salas et  al3 reported a 30.4% prevalence of dental erosion in chil‐
dren and adolescents, with high heterogeneity between the studies 
included in their assessment. Due to the progressive nature of dental 
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Abstract
Objectives: To assess the protective effects of a 0.454% stabilized stannous fluoride 
dentifrice and a marketed triclosan dentifrice against enamel erosion in a 10‐day in 
situ model.
Methods: This was a double‐blind, randomized, 2‐treatment, 4‐period, crossover in 
situ trial involving healthy adult participants. Participants were randomized to a 
treatment sequence involving the following products: a highly bioavailable 0.454% 
stannous fluoride dentifrice (Procter & Gamble) and a marketed dentifrice control 
containing 0.24% sodium fluoride and 0.3% triclosan (Colgate‐Palmolive). Each study 
period took place over 10 days. Participants wore an intra‐oral appliance retaining 
two polished human enamel samples for 6 hours per day. Two times per day they 
swished with the assigned dentifrice slurry and four times per day they swished with 
250 mL of orange juice (25 mL per minute) over a 10‐minute period. Contact pro‐
filometry measurements were made for each sample at baseline and day 10 to deter‐
mine surface change.
Results: Thirty‐six participants were enrolled and 33 completed the study (mean 
age = 40.5 years). The stannous fluoride dentifrice demonstrated 93.5% less enamel 
loss	than	the	NaF/triclosan	dentifrice	(P < 0.001) at Day 10, with median enamel loss 
of 0.097 µm and 1.495 µm, respectively. Both products were well tolerated.
Conclusion: The stannous fluoride dentifrice demonstrated significantly greater ero‐
sion	protection	efficacy	relative	to	the	NaF/triclosan	dentifrice	in	this	randomized	in	
situ clinical trial.
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erosion, it is not surprising that increases in tooth wear have been 
positively associated with age4,5; the longer we maintain our natural 
teeth, the more likely we are to experience conditions that are com‐
monly associated with dental erosion.
One of the primary factors associated with dental erosion is life‐
style. Lifestyle trends have changed significantly over the past few 
decades, such as the dramatic increase in the consumption of acid‐
containing drinks, particularly soft drinks, energy drinks and sports 
drinks, and foods.6,7 Multiple studies have confirmed significant in‐
creases in the consumption of these products.6‐10
Over the past several decades, we have gained a much better per‐
spective on the ability of daily hygiene practices, particularly those 
that include fluoride therapy, to help prevent and even reverse, the 
caries process.11‐13 Although similar in some aspects, dental erosion 
is different from caries. Due to the general irreversibility of erosion, 
many dental professionals are concerned that dental erosion could 
pose a significant threat to the long‐term health and integrity of 
tooth structure. As a result, preventive strategies designed to pro‐
tect exposed tooth surfaces against irreversible damage due to den‐
tal erosion are of high interest to the dental community.1,14	While	
some fluoride sources have been shown to provide a limited level of 
erosion protection, stannous fluoride, a multi‐benefit active used in 
some toothpastes, has been shown to provide significant anti‐erosion 
benefits in various types of laboratory studies.15‐18 There is a growing 
body of in situ evidence to support the claim that the use of stabilized 
stannous fluoride dentifrice is an effective means to help control both 
the initiation and progression of dental erosion in vivo.19‐24
The study reported here was the first to evaluate a high bioavail‐
able 1100 ppm fluoride stabilized stannous fluoride dentifrice rel‐
ative to a marketed 1100 ppm fluoride triclosan dentifrice control 
for erosion protection efficacy using an in situ erosion model with 
10‐day treatment periods.
2  | STUDY POPUL ATION AND METHODS
2.1 | Study population
Healthy male and female participants, 18 years of age or older, were 
recruited from staff at Bristol University and the Bristol Dental 
School and Hospital from April to June 2016. A sufficient number of 
participants were recruited to enrol approximately 36 participants in 
the study. Potential participants attended a screening visit approxi‐
mately one month before the start of the study.
Prior to receiving any study specific procedures, participants 
were asked to read a participant information sheet and sign an in‐
formed consent form. Qualified participants were required to have 
no evidence of the following: susceptibility to acid regurgitation; 
recurrent or regular aphthous ulcers; dental erosion or a previous 
history of susceptibility to high dental erosion after drinking sports 
drinks/juices; excessive gingival inflammation; severe periodontal 
disease; unremovable mouth or tongue jewellery. Participants had 
to agree to delay elective dentistry, and to refrain from participa‐
tion in any other product studies. Participants meeting all study 
entrance criteria were enrolled in the study and scheduled to return 
for treatment.
2.2 | Ethical considerations
This human in situ clinical study was granted ethical approval by the 
UK	National	Research	Ethics	Service	(NRES	Committee	South	West—
Central	Bristol,	REC	Ref:	15/SW/0266),	and	the	study	was	designed	
and managed in compliance with the principles of Good Clinical 
Practice. The study was conducted at the Clinical Trials Unit of Bristol 
Dental School and Hospital, Lower Maudlin Street, Bristol, UK.
2.3 | Randomization
Participants presented for four study periods and were randomized 
to one of four treatment sequences by a computer‐generated se‐
quence (AABB, BBAA, ABBA or BAAB, where the letters correspond 
to the two study treatments) that determined the participant's use of 
one of the two commercially available test dentifrices each period: (a) 
a highly bioavailable 0.454% stannous fluoride dentifrice (Crest® Pro‐
Health™ Advanced Gum Protection, Procter & Gamble, Cincinnati, 
OH, USA; 1100 ppm fluoride); or (b) a marketed dentifrice control 
containing 0.24% sodium fluoride and 0.3% triclosan (Colgate® 
Total®,	Colgate‐Palmolive,	New	York,	NY,	USA;	1100	ppm	fluoride).
2.4 | In situ study design
This was a single centre, double‐blind, randomized, two‐treatment, 
four‐period crossover study that was a variation of the previously 
published method of Hooper et  al24. During the screening visit 
prior to the start of study treatments, recruited participants were 
provided	 with	 a	 non‐treatment	 0.32%	 NaF	 (1450	ppm	 fluoride)	
marketed dentifrice (Crest® Decay Protection dentifrice, Procter & 
Gamble) and manual toothbrushes (Oral‐B®35 manual toothbrush, 
Procter & Gamble) to use at home, both prior to and during the 
course of the study. Participants were required to use these two 
F I G U R E  1   Intraoral appliance fitted with two enamel samples
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products in place of their normal oral care products, twice per day 
(morning and evening) for the duration of the study, including treat‐
ment days and weekends.
Study participants were fitted with an upper palatal intraoral ap‐
pliance	(Figure	1).	Each	appliance	was	fitted	with	two	enamel	samples	
derived from unerupted third molars from a Tooth Tissue Bank in the 
UK. Upon arrival at the clinical trials unit on each study treatment day, 
participants collected their intraoral appliance with the fitted enamel 
specimens and placed it in their mouth; wearing it for approximately 
6	hours	on	each	of	the	10	treatment	days.	While	wearing	the	appli‐
ance, participants swished twice each day for 60 seconds with their 
assigned dentifrice slurry at the clinical site. The slurry was prepared 
by the clinical site personnel as follows: Three (3.0) grams of den‐
tifrice were mixed with 10 mL of water, with participants being un‐
aware of the product identity of their assigned dentifrice slurry. The 
erosive challenge occurred four times on each day of the treatment 
phase	of	 the	study,	with	 the	 intraoral	appliance	 in	place.	 (Figure	2)	
Participants sipped 25 mL of orange juice (Sainsbury's Supermarkets 
Ltd, London, UK) over a timed minute, swished it around their mouth 
and then spat it out. This procedure was repeated 10 times so that 
the enamel samples were exposed to a total of 250 mL of orange juice 
over each 10‐minute period of erosive challenge. Each study period 
was comprised of 10 treatment days, with treatments being done 
only	on	weekdays	(Monday‐Friday)	over	a	span	of	about	2	weeks.	To	
ensure blinding, the investigator and personnel performing and re‐
cording the surface profilometry assessments had no access to the 
product dispensing room during treatments.
2.5 | Preparation and analysis of enamel samples
Prior to the start of the study, profilometry measurements were 
made on each sample using a calibrated contact surface profilometer 
(Mitutoyo (UK) Ltd, Andover, Hampshire, UK) to establish a baseline 
surface profile for each enamel specimen. At the end of the treat‐
ment phase of the study, each enamel sample was again measured 
using the same profilometry method, and tissue loss was calculated. 
Fresh	samples	of	human	enamel	were	fitted	into	the	intra‐oral	ap‐
pliance at the beginning of each of the four treatment periods. A 
detailed description of procedures related to the acquisition, sterili‐
zation, preparation and analysis of human enamel test specimens has 
been described previously.24
2.6 | Determination of sample size
Using 36 participants, at least 80% power to detect a two‐sided 5% 
significant difference between the treatment dentifrices would be 
achieved provided the natural log scale effect size (mean difference 
divided by the error standard deviation) was 0.70 or greater for this 
crossover design.
2.7 | Statistical methods
The primary measure of efficacy in the in situ trial was the amount 
of dental erosion that had occurred, measured by profilometry, 
after 10 days of treatment. The average of four erosion measure‐
ments was calculated from each of the two enamel specimens for 
each study participant at each visit. Since the Day 10 enamel loss 
distribution is right‐skewed, the data were transformed using the 
natural log function before performing statistical analysis. A general 
linear mixed model was used to compare treatments with a statisti‐
cal model that included period and treatment as fixed effect, partici‐
pants as a random effect and baseline as covariate. The carry‐over 
effect was not statistically significant (P > 0.31) and excluded from 
the	model.	From	the	statistical	model,	estimated	means	on	the	natu‐
ral log scale were back‐transformed by using the exponential func‐
tion (emean) to obtain the estimated median or 50th percentiles on 
the original scale (µm), along with the associated standard errors 
and/or 95% confidence intervals (CI). Statistical comparisons were 
two‐sided at a 5% significance level.
The null hypothesis tested at Day 10 in this human in situ clini‐
cal study was that the mean dental erosion was equal between the 
two treatment dentifrices, and the alternative hypothesis was that 
the mean dental erosion was not equal between the two treatment 
dentifrices.
3  | RESULTS
In this randomized in situ clinical evaluation, 36 participants 
ranging in age from 20‐60 (mean age 40.5 years) were enrolled and 
35 were randomized to treatment. Twenty‐four (69%) participants 
F I G U R E  2   Study design with treatment and acid challenge 
schedule
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were female. (Table 1). Thirty‐three (33) participants completed the 
study, and all study data were deemed evaluable. Three participants 
dropped due to voluntary withdrawal from the study.
At Day 10, the stabilized stannous fluoride dentifrice demon‐
strated 93.5% less enamel loss (P	<	0.0001)	 vs	 the	 NaF/triclosan	
multi‐benefit dentifrice, with estimated enamel loss medians (CI) 
of 0.097 µm (0.074, 0.127) for the stabilized stannous fluoride 
dentifrice	and	1.495	µm	(1.157,	1.931)	for	the	NaF/triclosan	denti‐
frice (Table 2). Distribution Box Plots of enamel loss by treatment 
(Figure	 3)	 verify	 distinct	 differences	 in	 performance	 between	 the	
two test dentifrices at Day 10.
Both	 dentifrices	 were	 well	 tolerated.	 No	 significant	 adverse	
events were reported.
4  | DISCUSSION
This study, using 10‐day treatment periods, demonstrated a sig‐
nificant erosion protection benefit of 93.5% for the multi‐benefit, 
1100 ppm fluoride, high bioavailable stabilized stannous fluoride 
dentifrice compared to the triclosan‐containing dentifrice formu‐
lated	with	1100	ppm	fluoride	as	NaF.	These	 results	are	consistent	
with other in situ clinical studies in the literature that have similarly 
demonstrated enhanced erosion protection, ranging from 27% to 
94%, delivered from stabilized stannous fluoride dentifrices com‐
pared to other dentifrices that are not formulated with this ingre‐
dient.19‐24	For	example,	a	similar	study	by	West	et		al19 found 68% 
greater erosion protection for a 0.454% stannous fluoride plus 
0.077% sodium fluoride (1450 ppm fluoride) dentifrice marketed in 
the	United	Kingdom	compared	to	a	1450	ppm	fluoride	NaF/triclosan	
dentifrice after 15 days of treatment and a 67% benefit after 10 
treatment days. These study results are also consistent with recom‐
mendations from professional groups and organizations.25,26 A re‐
cent	consensus	report	by	the	European	Federation	of	Conservative	
Dentistry noted that dentifrices containing stannous fluoride have 
the potential for slowing erosive tooth wear, while data for other 
products is limited.26
Although both dentifrices included in the current study are mar‐
keted as being “multi‐benefit” products, protection against dental 
erosion is determined, in part, by the ability of a dentifrice to deposit 
a protective, acid‐resistant barrier layer onto the surface of treated 
teeth. Stabilized stannous fluoride is capable of depositing such a 
layer. Mechanism of action studies found that stannous fluoride pro‐
vides erosion benefits through the deposition of a transparent, pro‐
tective barrier layer onto the enamel surface that provides enhanced 
resistance against erosive acid challenges.16,17,27	Figure	4	shows	im‐
ages of etched enamel slabs treated with stannous fluoride, sodium 
fluoride, sodium monofluorophosphate or amine fluoride slurries 
and stained with 2% alizarin Red‐S.28 The slab treated with stannous 
fluoride showed little evidence of staining with the dye, indicating 
that it had formed a surface layer that protected against dye depo‐
sition. Stannous fluoride is able to incorporate onto both smooth 
and pellicle‐coated surfaces. The barrier layer that forms on pelli‐
cle‐coated enamel, likely composed of metal‐rich precipitates such 
as Sn3F3PO4,	Ca(SnF3)2 or SnOHPO4,
29,30 increases with continued 
use and is retained on treated tooth surfaces for extended periods of 
time, strengthening the enamel surface against subsequent acid at‐
tacks.16,27 Early stannous fluoride formulations were associated with 
the potential for surface stain, but contemporary formulas contain 
stain‐mitigating ingredients, such as the sodium hexametaphosphate 
in this formula, that can actually provide extrinsic whitening.31,32
One might argue the erosion protection benefits of oral care 
products should be demonstrated in long‐term human erosion clin‐
ical studies; however, given the slow progression of the condition, 
the general irreversibility of dental erosion and ethical consider‐
ations, such studies are impractical. Properly controlled in situ stud‐
ies provide a reasonable clinical alternative for assessing relative 
erosion protection performance in relatively short periods of time, 
while minimizing the risk to participants’ natural tooth surfaces.
While	dental	erosion	follows	a	path	that	is,	in	some	ways,	similar	
to the demineralization aspects of caries (ie, tooth mineral is lost due 
to an acid challenge), dental erosion is different; it primarily occurs 
as a loss of surface, rather than subsurface mineral.1 This key factor 
makes it far more difficult to restore lost mineral through the rem‐
ineralization process. Although remineralization via fluoride therapy 
TA B L E  1   Study demographics
Demographic Statistic or category Value
Age (y) Mean (SD) 40.5 (13.48)
Min.–Max. 20‐60
Ethnicitya Asian Indian 2 (6%)
Asian Oriental 1 (3%)
Caucasian 32 (91%)
Gendera Female 24 (69%)
Male 11 (31%)
aThe number and percent of subjects in each category. 
Treatment
Original scale in µm 
estimated median (95% CI)
Natural Log 
Scale 
Mean (SE)
% Less erosion vs 
NaF/triclosan 
(P‐value)a
Stannous fluoride 0.097 (0.074, 0.127) −2.336	(0.136) 93.5% (P < 0.0001)
NaF/triclosan 1.495 (1.157, 1.931) 0.401 (0.128)
aCalculated from estimated medians in μm	as	100%	 (NaF/triclosan—Stannous	 fluoride	divided	by	
NaF/triclosan).	
TA B L E  2   Enamel loss (µm) treatment 
comparison at Day 10
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works well in areas of subsurface demineralization, physical chal‐
lenges to surface minerals, even after fluoride exposure, may be too 
much for the softened mineral to withstand the level of abrasion that 
occurs in the mouth on an almost constant basis. Even the tongue 
can present an almost constant abrasive factor, as it comes into con‐
tact with exposed tooth surfaces on a routine basis.33,34
The goal of any product intended to help prevent dental ero‐
sion is to maintain the integrity of the sound enamel surface. The 
current model is designed with this in mind, as it assesses the 
ability of test products to protect sound enamel against erosive 
softening of the surface mineral that can lead to erosive tissue 
loss. The erosive challenges, two of which occurred shortly after 
dentifrice treatment and two of which occurred a few hours 
post‐treatment, were intended to reflect different time intervals 
in which erosive challenges might occur post‐brushing over the 
course	of	a	participant's	routine	day.	While	these	time	intervals	
might not be exactly the same as those that might occur on a daily 
basis, the schedule provides a standardized challenge for each 
treatment group to maximize similarities between treatments 
and	minimize	variances.	Focusing	on	prevention,	the	model	does	
not incorporate direct, physical brushing of the enamel spec‐
imens. Physical abrasion is only an issue after the surface has 
been erosively softened. In vivo, the fluoride‐rich outer layer 
of enamel, along with the natural pellicle, provides protection 
against both erosive and abrasive challenges; however, with suf‐
ficient challenge, this protective layer is overwhelmed and ero‐
sive tissue loss can progress. Treatment of the specimens with 
slurries, rather than direct brushing, helps ensure that the model 
remains focused on the preventive aspect of the treatment. By 
treating all specimens in the same manner, the model measures 
the relative abilities of the various test products to protect the 
treated enamel against the erosive acid insult. The ability of 
stannous fluoride to deposit an acid‐resistant barrier layer onto 
treated tooth surfaces confirms that this protected mineral was 
not lost as a result of acid softening, erosive processes. The pre‐
ventive benefits of stannous fluoride therapy are clearly evident 
in the current study, with the differences between the two test 
products being highly significant.
5  | CONCLUSION
The stannous fluoride dentifrice included in this randomized in situ 
clinical trial demonstrated significantly greater erosion protection 
F I G U R E  3   Box plot of data showing individual and averaged 
enamel loss data points for each of the two test dentifrices
F I G U R E  4   Dye deposition on acid etched enamel samples following treatment with toothpaste/saliva slurry. Samples were treated with 
a toothpaste/saliva slurry (1100 ppm stannous fluoride, 1100 ppm sodium fluoride, 1000 ppm sodium monofluorophosphate or 1400 ppm 
amine fluoride) and exposed to 2% alizarin Red‐S following rinsing. Dye deposition was evaluated using a 5‐point scale; 0 indicates no dye 
deposition and 4 indicates complete dye coverage. A low score signifies the presence of a barrier layer preventing dye deposition28
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efficacy	relative	to	the	NaF/triclosan	dentifrice.	The	use	of	a	clini‐
cally proven stannous fluoride dentifrice is both a convenient and 
economical way to incorporate a preventive strategy for dental ero‐
sion into patients’ daily oral hygiene regimen.
6  | CLINIC AL RELE VANCE
6.1 | Scientific rationale for study
Dental erosion is a growing global oral care issue, and stabilized 
stannous fluoride dentifrices have been consistently proven to help 
control both the initiation and progression of this condition better 
than other tested products.
6.2 | Principal findings
This in situ clinical study demonstrated greater erosion protection 
potential of a stabilized stannous fluoride dentifrice compared to a 
NaF/triclosan	dentifrice.
6.3 | Practical implications
Stabilized stannous fluoride dentifrices should be strongly 
recommended as part of a comprehensive daily oral hygiene 
plan, especially for those patients at risk of developing dental 
erosion.
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